Celebrities like Tom Brady and Tiger Woods support the project. The Dallas-based biotechnology firm, founded by Ben Lamm, has emerged as a trailblazer in de-extinction science. But Lamm is clear ...

The Basel Area in Switzerland is home to one of Europe’s brightest biotech ecosystems. Over the years, it has proven to be the favored location for many of the world’s biggest, best, and newest ...

Houston-based clinical-stage biotechnology company FibroBiologics Inc. opened a manufacturing laboratory at 9350 Kirby Drive in the Texas Technology Park. It will bring manufacturing operations in ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

It’s a biotech en­vi­ron­ment with­out many good choic­es. Even be­fore Pres­i­dent Don­ald Trump’s tar­iff an­nounce­ment pushed stock in­dices to­ward a bear mar­ket ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived. From cautious employers to ...

Caitlin O'Kane is a New York City journalist who works on the CBS News social media team as a senior manager of content and production. She writes about a variety of topics and produces "The ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

Legend Biotech has no tariff exposure and manufactures Carvykti entirely in the U.S. for both U.S. and EU markets. HC Wainwright maintains a $75 target, citing Carvykti’s strong efficacy and ...

Colossal Biosciences Colossal Biosciences Inc., a Dallas-based biotech firm with a $10 billion valuation, has announced a new breakthrough in its audacious mission to resurrect extinct animals.